152
Views
6
CrossRef citations to date
0
Altmetric
Original

A precise pharmacodynamic study showing the advantage of a marked reduction in cardiotoxicity in continuous infusion of doxorubicin

, , , , , , & show all
Pages 1599-1607 | Received 09 Aug 2005, Accepted 02 Jan 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Steven E. Lipshultz, Harvey Cohen, Steven D. Colan & Eugene H. Herman. (2006) The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity. Leukemia & Lymphoma 47:8, pages 1454-1458.
Read now

Articles from other publishers (5)

Chen Guo, Haoyang Yuan, Yuxiu Wang, Yupeng Feng, Yu Zhang, Tian Yin, Haibing He, Jingxin Gou & Xing Tang. (2023) The interplay between PEGylated nanoparticles and blood immune system. Advanced Drug Delivery Reviews 200, pages 115044.
Crossref
Yadir A. Guerrero, Diti Desai, Connor Sullivan, Erick Kindt, Mary E. Spilker, Tristan S. Maurer, Deepak E. Solomon & Derek W. Bartlett. (2020) A Microfluidic Perfusion Platform for In Vitro Analysis of Drug Pharmacokinetic-Pharmacodynamic (PK-PD) Relationships. The AAPS Journal 22:2.
Crossref
Trevi R. Mancilla, Brian Iskra & Gregory J. Aune. 2011. Comprehensive Physiology. Comprehensive Physiology 905 931 .
Sumati Gupta, Launce Gouw, Jennifer Wright, Sant Chawla, Debbie Pitt, Mark Wade, Ken Boucher & Sunil Sharma. (2016) Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation. Investigational New Drugs 34:2, pages 243-252.
Crossref
Merry L. LindseyRichard A. LangeHelen Parsons, Thomas Andrews & Gregory J. Aune. (2014) The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure. American Journal of Physiology-Heart and Circulatory Physiology 307:10, pages H1379-H1389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.